mylife Diabetes Care Denmark ApS

Private limited companyCVR 39888041København KActive

mylife Diabetes Care Denmark ApS is a private limited company, based in København K, active in wholesale of pharmaceutical goods and nursing supplies, founded in 2018. Net profit rose 97% from 2025 to 2026, ending at DKK 850k. Profit has grown three years in a row. Equity grew to DKK 5.8m in 2026.

Follow
PDF reportCompare

Key figures · financial year 2026

Gross profitDKK 9.5m+83.4% vs. 2025
Net profitDKK 850k+96.9% vs. 2025
EquityDKK 5.8m+17.2% vs. 2025
Employees6latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2026 against 2025

  • Gross profit rose 83% (2025 → 2026), to DKK 9.5m.
  • Net profit rose 97% (2025 → 2026), to DKK 850k.
  • Equity rose 17% (2025 → 2026), to DKK 5.8m.

Management and owners, last 24 months

  • New in management: Agnès Claire Francoise Simon (chair of the board, 16/01/2025), Beat Keller (deputy chair, 16/01/2025) and Johan Conny Lundström (board member, 16/01/2025).
  • Stepped down: Niklaus Ramseier (board member, 16/01/2025), Simon Michel (board member, 16/01/2025) and Dirk Scherff (board member, 16/01/2025).
  • New owners registered: mylife Diabetes Care AG (09/12/2024).
  • No longer registered as owner: Ypsomed AG (09/12/2024).

Registrations, last 24 months

  • 01/04/2026: Name changed from Ypsomed ApS to mylife Diabetes Care Denmark ApS

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2021–2026 · amounts in DKK thousand

Equity and net profit

DKK 0DKK 1mDKK 2mDKK 3mDKK 4mDKK 5mDKK 6m202120222023202420252026
EquityNet profit
Financial figures for mylife Diabetes Care Denmark ApS
202120222023202420252026Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit2,5472,6652,8384,1955,1819,501+83.4%
Operating profit (EBIT)149152255––1,116–
Profit before tax1201362584555601,099+96.2%
Net profit92105199323432850+96.9%
Total assets5,5005,1346,9917,6068,87115,710+77.1%
Equity3,8933,9994,1984,5214,9535,803+17.2%
Liabilities1,6071,1362,7933,0853,9189,908+152.9%
Cash and cash equivalents8373962,4221,3722,0993,420+63%
Average number of employees7335550%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2021, 2022, 2023, 2024, 2025, 2026: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 5mDKK 10mDKK 15mDKK 20m202120222023202420252026
Gross profitMedian, the industry (232 companies)

Signals from the financial statements

calculated from the 2026 figures
  • Profit for five years in a row

    Net result has been positive in 2022–2026.

    How is this calculated?

    Net result is positive in the five latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for mylife Diabetes Care Denmark ApS
Financial yearPeriodPublishedFigures forDocuments
202601/04/2025 – 31/03/202630/09/2026The companyPDF not statedXBRL
202501/04/2024 – 31/03/202530/09/2025The companyPDF not statedXBRL
202401/04/2023 – 31/03/202404/10/2024The companyPDFXBRL
202301/04/2022 – 31/03/202303/07/2023The companyPDFXBRL
202201/04/2021 – 31/03/202204/07/2022The companyPDFXBRL
202101/04/2020 – 31/03/202116/07/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0123456708/2309/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/26
Employees

Position in the industry

232 companies in the database

Comparison with the other companies in wholesale of pharmaceutical goods and nursing supplies based on the latest financial year.

Gross profitDKK 9.5mNo. 126 of 232
Better than 46% of the companies in the industry
EquityDKK 5.8mNo. 133 of 232
Better than 43% of the companies in the industry
Number of employees6No. 134 of 232
Better than 42% of the companies in the industry

Industry median: gross profit DKK 11.2m, net profit DKK 1.8m, equity DKK 9.6m, 9 employees.

DKK 100kDKK 1.4mDKK 19.1mDKK 263.2mDKK 1.5bnHere
Distribution of gross profit for 225 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 5,247of 69,742
Better than 92%
No. 12,851of 69,964
Better than 82%
Same industry and fewer than 20 employees150 companies in the comparison
No. 46of 150
Better than 70%
No. 57of 150
Better than 62%
Companies that are between 5 and 14 years old33,688 companies in the comparison
No. 4,639of 33,588
Better than 86%
No. 5,472of 33,687
Better than 84%
All companies of type ApS66,508 companies in the comparison
No. 6,520of 66,379
Better than 90%
No. 10,113of 66,505
Better than 85%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Wholesale of pharmaceutical goods and nursing supplies
Gross profit
  1. mylife Diabetes Care Denmark ApSDKK 9.5m
  2. Ambu A/SDKK 3.6bn
  3. Stada Nordic ApSDKK 687m
Net profit
  1. mylife Diabetes Care Denmark ApSDKK 850k
  2. Ambu A/SDKK 609m
  3. Stada Nordic ApSDKK 54.6m
Equity
  1. mylife Diabetes Care Denmark ApSDKK 5.8m
  2. Ambu A/SDKK 6bn
  3. Stada Nordic ApSDKK 346.3m
Employees
  1. mylife Diabetes Care Denmark ApS6
  2. Ambu A/S619
  3. Stada Nordic ApS51

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • mylife Diabetes Care AG100%
mylife Diabetes Care Denmark ApS

Management

4 active registrations

Executive management

Executive management at mylife Diabetes Care Denmark ApS
NameRoleAppointed
Anja Pihl BovienDirector24/09/2018

Board of directors

Board of directors at mylife Diabetes Care Denmark ApS
NameRoleAppointed
Agnès Claire Francoise SimonChair of the board16/01/2025
Beat KellerDeputy chair16/01/2025
Johan Conny LundströmBoard member16/01/2025
Founders
Ypsomed Aktiebolag
Former management (4)
Former management at mylife Diabetes Care Denmark ApS
NameRoleAppointedResigned
Niklaus RamseierBoard member24/09/201816/01/2025
Simon MichelBoard member24/09/201816/01/2025
Eberhard BauerBoard member24/09/201822/02/2022
Dirk ScherffBoard member22/02/202216/01/2025

Signing rule: Selskabet tegnes af 1 direktør eller af den samlede bestyrelse.

Address and production units

1 active production units

Hammerensgade 1
1267 København K

København Municipality · Postcode 1267

Other companies at the address (8)

Production units
Production unitAddressEmployeesP number
mylife Diabetes Care Denmark ApSHammerensgade 1, 2, 1267 København K61023983865

Purpose

Selskabets formål er at drive virksomhed med salg af diabeteshjælpemidler til danske forbrugere samt anden virksomhed, der står i forbindelse hermed.

The purpose is quoted from the register in Danish.

Changes year by year

28 registered events
20262 changesaccounts 1 · name 1
  • Annual report for 2026 published
  • Name changed from Ypsomed ApS to mylife Diabetes Care Denmark ApS
20257 changesaccounts 1 · management 6
  • Annual report for 2025 published
  • Agnès Claire Francoise Simon appointed chair of the board
  • Beat Keller appointed deputy chair
  • Johan Conny Lundström appointed board member
  • Dirk Scherff stepped down as board member
  • Simon Michel stepped down as board member
  • Niklaus Ramseier stepped down as board member
20243 changesownership 2 · accounts 1
  • mylife Diabetes Care AG registered as owner (100%)
  • Ypsomed AG is no longer registered as owner
  • Annual report for 2024 published
20232 changesaddress 1 · accounts 1
  • Moved to Hammerensgade 1, 2, 1267 København K
  • Annual report for 2023 published
20224 changesaddress 1 · accounts 1 · management 2
  • Moved to Hammerensgade 1, 2, 1267 København K
  • Annual report for 2022 published
  • Dirk Scherff appointed board member
  • Eberhard Bauer stepped down as board member
20212 changesaddress 1 · accounts 1
  • Moved to Marielundvej 20, 2730 Herlev
  • Annual report for 2021 published
20188 changesownership 3 · founded 1 · management 4
  • Ypsomed AG registered as owner (100%)
  • Ypsomed Aktiebolag is no longer registered as owner
  • Registered as Ypsomed ApS
  • Anja Pihl Bovien appointed director
  • Simon Michel appointed board member
  • Eberhard Bauer appointed board member
  • Niklaus Ramseier appointed board member
  • Ypsomed Aktiebolag registered as owner (100%)

Related companies

Same industry in København

See all →

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction